Rash & Diarrhea Prophylaxis With Capivasertib

Clinical trial NCT07426822 · RECRUITING

Trial details

NCT number: NCT07426822
Sponsor: Maryam Lustberg
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic HR+/HER2- Breast Cancer

Start date: 2026-08-15
Primary completion: 2027-04-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.